ARID1B degrader (Foghorn Therapeutics)

N/A

Report date: 2025/05/12 15:27:18
NME

Base Information

Drug NameARID1B degrader (Foghorn Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAT-rich interactive domain-containing protein 1B degraders
TargetsAT-rich interactive domain-containing protein 1B
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFoghorn Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesFoghorn Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A